| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |